logo

For the Inventor, By the Inventor

Basking Ridge, NJ, United States of America

Ping Li

This inventor holds 6 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Array Biopharma Inc., Novartis Ag. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ping Li. Retrieved from https://idiyas.com/inventor/ping-li-ez1zv8e6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 66.7

 

Average Co-Inventor Count = 6.8

ph-index = 4

Forward Citations = 40(Granted Patents)


Company Filing History:

goldMedal3 out of 333 
 
Array Biopharma Inc.
 patents
silverMedal3 out of 3,977 
 
Novartis Ag
 patents

Years Active: 2013-2020

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 10561654 - Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (2020-02-18),
2. 10258622 - Method of treating colorectal cancer by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)pheny1)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl) carbamate (2019-04-16),
3. 9763941 - Method of treating melanoma by administration of pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (2017-09-19),
4. 9387208 - Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate (2016-07-12),
5. 9301957 - Immediate release 4-methyl-3-4[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-YL)-3-(trifluoromethyl)phenyl] benzamide formulation (2016-04-05),
6. 8475839 - Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same (2013-07-02),

Title: Innovator Ping Li: A Pioneer in Pharmaceutical Formulations

Introduction

Ping Li, a notable inventor based in Basking Ridge, NJ, has made significant contributions to the field of pharmaceuticals. With a total of six patents to his name, his work primarily focuses on developing effective formulations for treating various proliferative diseases, including solid tumors.

Latest Patents

Among his latest inventions is a patent for pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate, referred to as COMPOUND A. This invention targets solid oral pharmaceutical formulations to aid in the treatment of solid tumor diseases. Additionally, he has developed a method specifically for treating colorectal cancer through the administration of the same formulations, highlighting his commitment to advancing cancer therapies.

Career Highlights

Throughout his career, Ping Li has collaborated with prominent companies such as Novartis AG and Array Biopharma Inc., where he made impactful contributions to drug development and pharmaceutical research. His work reflects his dedication to enhancing treatment options for patients suffering from debilitating diseases.

Collaborations

In his professional journey, Ping Li has worked closely with esteemed colleagues, including Daya Verma and Xiaohong Shen. Their collaborative efforts have further enriched the innovations emerging in the realm of pharmaceutical sciences.

Conclusion

Ping Li stands as a prominent inventor whose contributions to pharmaceutical formulations are poised to influence the future of cancer treatment and patient care. His patents not only exemplify innovation but also demonstrate a commitment to improving healthcare solutions for those affected by serious illnesses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…